Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Circulation|June 15, 1999
Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in miceL E Rohde, A Ducharme, L H Arroyo, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2018
Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9Allyn T Londregan, Gary Aspnes, Chris Limberakis, et al.
ACS Central Science|October 28, 2024
Activity-Based DNA-Encoded Library Screening for Selective Inhibitors of Eukaryotic TranslationHuda Barhoosh, Anjali Dixit, Wesley G Cochrane, et al.
British Journal of Pharmacology|January 20, 2016
Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivoJ Kong, J Chuddy, I A Stock, et al.
Biopharmaceutics & Drug Disposition|September 1, 2006
Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomesAmit S Kalgutkar, Heather L Hatch, Frederick Kosea, et al.
American Journal of Clinical Pathology|August 16, 2015
Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosisKaaren K Reichard, Dong Chen, Animesh Pardanani, et al.
Chemical Research in Toxicology|February 4, 2011
Intrinsic electrophilicity of a 4-substituted-5-cyano-6-(2-methylpyridin-3-yloxy)pyrimidine derivative: structural characterization of glutathione conjugates in vitroAmit S Kalgutkar, Vincent Mascitti, Raman Sharma, et al.
Blood|July 27, 2006
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patientsAnimesh D Pardanani, Ross L Levine, Terra Lasho, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 9, 2007
Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activationAmit S Kalgutkar, Deepak K Dalvie, Jiri Aubrecht, et al.
Leukemia|May 29, 2010
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosisA Tefferi, T L Lasho, O Abdel-Wahab, et al.
Pageof 11